(MEG) Montrose Environmental Grp - Overview
Stock: Assessment, Testing, Remediation, Consulting, Laboratories
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 63.3% |
| Relative Tail Risk | -10.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.51 |
| Alpha | 0.78 |
| Character TTM | |
|---|---|
| Beta | 1.368 |
| Beta Downside | 0.802 |
| Drawdowns 3y | |
|---|---|
| Max DD | 79.99% |
| CAGR/Max DD | -0.28 |
Description: MEG Montrose Environmental Grp January 20, 2026
Montrose Environmental Group, Inc. (NYSE: MEG) is a U.S.–based environmental-services firm founded in 2012 and headquartered in North Little Rock, Arkansas. It operates across three segments-Assessment, Permitting & Response; Measurement & Analysis; and Remediation & Reuse-serving clients in oil & gas, utilities, government, manufacturing, transportation, chemicals, renewable energy, aerospace, telecom and engineering.
In FY 2023 the company reported roughly $210 million in revenue with an adjusted EBITDA margin near 12%, reflecting steady demand for its scientific advisory, laboratory testing, and engineered treatment solutions. Two macro-drivers underpin this growth: (1) tightening U.S. and Canadian environmental regulations that increase spending on compliance and remediation, and (2) rising ESG-related capital allocation that pushes industrial operators toward more sustainable water-treatment and waste-to-energy technologies. The broader Environmental & Facilities Services sub-industry is expanding at an estimated 5% CAGR through 2028, outpacing general industrial services.
If you want a data-rich, quantitative overlay on MEG’s valuation and risk profile, a quick look at ValueRay’s analyst toolkit can provide the next layer of insight.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: -20.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 9.63 > 1.0 |
| NWC/Revenue: 12.30% < 20% (prev 17.63%; Δ -5.34% < -1%) |
| CFO/TA 0.09 > 3% & CFO 87.5m > Net Income -20.8m |
| Net Debt (362.9m) to EBITDA (70.8m): 5.12 < 3 |
| Current Ratio: 1.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.9m) vs 12m ago 16.63% < -2% |
| Gross Margin: 40.77% > 18% (prev 0.39%; Δ 4037 % > 0.5%) |
| Asset Turnover: 82.94% > 50% (prev 66.85%; Δ 16.09% > 0%) |
| Interest Coverage Ratio: 0.68 > 6 (EBITDA TTM 70.8m / Interest Expense TTM 19.5m) |
Altman Z'' -0.65
| A: 0.10 (Total Current Assets 256.0m - Total Current Liabilities 154.4m) / Total Assets 985.7m |
| B: -0.27 (Retained Earnings -265.3m / Total Assets 985.7m) |
| C: 0.01 (EBIT TTM 13.3m / Avg Total Assets 996.3m) |
| D: -0.51 (Book Value of Equity -269.3m / Total Liabilities 527.0m) |
| Altman-Z'' Score: -0.65 = B |
Beneish M -3.13
| DSRI: 0.87 (Receivables 234.1m/218.4m, Revenue 826.3m/673.1m) |
| GMI: 0.97 (GM 40.77% / 39.36%) |
| AQI: 0.98 (AQ_t 0.62 / AQ_t-1 0.63) |
| SGI: 1.23 (Revenue 826.3m / 673.1m) |
| TATA: -0.11 (NI -20.8m - CFO 87.5m) / TA 985.7m) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of MEG shares?
Over the past week, the price has changed by +10.82%, over one month by -4.56%, over three months by -2.06% and over the past year by +17.74%.
Is MEG a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MEG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.3 | 35% |
| Analysts Target Price | 33.3 | 35% |
| ValueRay Target Price | 21.7 | -12% |
MEG Fundamental Data Overview February 03, 2026
P/B = 1.7102
Revenue TTM = 826.3m USD
EBIT TTM = 13.3m USD
EBITDA TTM = 70.8m USD
Long Term Debt = 302.4m USD (from longTermDebt, last quarter)
Short Term Debt = 27.9m USD (from shortTermDebt, last quarter)
Debt = 369.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 362.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.15b USD (787.3m + Debt 369.6m - CCE 7.84m)
Interest Coverage Ratio = 0.68 (Ebit TTM 13.3m / Interest Expense TTM 19.5m)
EV/FCF = 15.56x (Enterprise Value 1.15b / FCF TTM 73.9m)
FCF Yield = 6.43% (FCF TTM 73.9m / Enterprise Value 1.15b)
FCF Margin = 8.94% (FCF TTM 73.9m / Revenue TTM 826.3m)
Net Margin = -2.52% (Net Income TTM -20.8m / Revenue TTM 826.3m)
Gross Margin = 40.77% ((Revenue TTM 826.3m - Cost of Revenue TTM 489.4m) / Revenue TTM)
Gross Margin QoQ = 39.40% (prev 43.38%)
Tobins Q-Ratio = 1.17 (Enterprise Value 1.15b / Total Assets 985.7m)
Interest Expense / Debt = 1.42% (Interest Expense 5.24m / Debt 369.6m)
Taxrate = 46.50% (7.28m / 15.7m)
NOPAT = 7.13m (EBIT 13.3m * (1 - 46.50%))
Current Ratio = 1.66 (Total Current Assets 256.0m / Total Current Liabilities 154.4m)
Debt / Equity = 0.81 (Debt 369.6m / totalStockholderEquity, last quarter 458.7m)
Debt / EBITDA = 5.12 (Net Debt 362.9m / EBITDA 70.8m)
Debt / FCF = 4.91 (Net Debt 362.9m / FCF TTM 73.9m)
Total Stockholder Equity = 486.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.09% (Net Income -20.8m / Total Assets 985.7m)
RoE = -4.29% (Net Income TTM -20.8m / Total Stockholder Equity 486.5m)
RoCE = 1.69% (EBIT 13.3m / Capital Employed (Equity 486.5m + L.T.Debt 302.4m))
RoIC = 0.99% (NOPAT 7.13m / Invested Capital 717.7m)
WACC = 7.70% (E(787.3m)/V(1.16b) * Re(10.96%) + D(369.6m)/V(1.16b) * Rd(1.42%) * (1-Tc(0.46)))
Discount Rate = 10.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 14.96%
[DCF Debug] Terminal Value 71.62% ; FCFF base≈73.9m ; Y1≈48.5m ; Y5≈22.1m
Fair Price DCF = 2.66 (EV 457.0m - Net Debt 362.9m = Equity 94.1m / Shares 35.3m; r=7.70% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 61.74 | EPS CAGR: 26.30% | SUE: 0.32 | # QB: 0
Revenue Correlation: 90.15 | Revenue CAGR: 12.67% | SUE: 1.41 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.18 | Chg30d=+0.055 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=1.40 | Chg30d=-0.001 | Revisions Net=-1 | Growth EPS=+10.4% | Growth Revenue=+2.9%